l The figure sanofi aventis is the United States morningstat data, the top 25 largest stock U.S. Nasdaq Composite Index, YTD Return is the gain so far this year (as of 2013-8-2) through the icon, you can see the computer technology stocks accounted for a high weight, But the contribution of the index is very limited, while more than 50 percent of it is very strange to many of you would not invest in the company or usual, Gilead, Biogen, Celgene, Facebook, etc.
l Gilead, Biogen, Celgene is a new industry in the United States in recent years, rapid growth, and the market capitalization of these companies have reached, there is a rapid rise in recent years the industry is biotechnology industry (Biotech), the biotech industry's market capitalization has can challenge you more familiar with traditional sanofi aventis pharmaceutical companies, including Merck, Pfizer, Glaxo, etc., I was writing the pilot Franklin Biotechnology Fund: slightly behind sanofi aventis the broader sanofi aventis market's proactive fund biotech industry, this article, who wrote several a situation the American biotech stocks, you might be interested revisit it, I simply described as follows
l year ended July 30, before the Nasdaq sanofi aventis Biotechnology sanofi aventis Index five heavyweight Gilead sanofi aventis Sciences, Amgen, Celgene, bio-genetic, pharmaceutical regeneration yuan this year, the cumulative increase reached 68.09%, 29%, 85.26%, 48.21% , 59.98%.
The Author: Jimmy Dawson is a group of passive investment focus on research methods and passive tools team, Jimmy Dawson's name originated from a classic book "Value Averaging-By Micheal.E Edleson", we have the passion, love to explore, to pursue closer Truth investment approach, hoping in the era of information explosion, providing a simple and efficient approach to investing, sanofi aventis serving on the market "vulnerable" in the investing public, e-mail is m.edleson@gmail.com
Simple template. Provided by Blogger technology.
No comments:
Post a Comment